Connected insulin systems in diabetes patients in Spain: Present and future perspectives

Affiliations

¹ Diabetes Unit, Department of Endocrinology and Nutrition, Hospital Clínic i Universitari, Barcelona, Spain; CIBERDEM, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas [Biomedical Research Network Centre for Diabetes and Metabolic Diseases], Madrid, Spain; IDIBAPS, Institut d'Investigacions Biomèdiques August Pi i Sunyer [August Pi i Sunyer Biomedical Research Institute], Barcelona, Spain.
² Eli Lilly and Company, Alcobendas, Madrid, Spain.
³ Eli Lilly and Company, Alcobendas, Madrid, Spain. Electronic address: duque_natalia@lilly.com.

Comment

Ignacio Conget et al. Endocrinol Diabetes Nutr (Engl Ed). 2023 Feb.

. 2023 Feb;70(2):155-157.

doi: 10.1016/j.endien.2022.10.006.

¹ Diabetes Unit, Department of Endocrinology and Nutrition, Hospital Clínic i Universitari, Barcelona, Spain; CIBERDEM, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas [Biomedical Research Network Centre for Diabetes and Metabolic Diseases], Madrid, Spain; IDIBAPS, Institut d'Investigacions Biomèdiques August Pi i Sunyer [August Pi i Sunyer Biomedical Research Institute], Barcelona, Spain.
² Eli Lilly and Company, Alcobendas, Madrid, Spain.
³ Eli Lilly and Company, Alcobendas, Madrid, Spain. Electronic address: duque_natalia@lilly.com.

No abstract available

Comment on

Digital Diabetes Management: A Literature Review of Smart Insulin Pens.
Heinemann L, Schnell O, Gehr B, Schloot NC, Görgens SW, Görgen C. Heinemann L, et al. J Diabetes Sci Technol. 2022 May;16(3):587-595. doi: 10.1177/1932296820983863. Epub 2021 Jan 11. J Diabetes Sci Technol. 2022. PMID: 33430644 Free PMC article. Review.